Japan gives $85M to zap polio in Nigeria; Malaria-immune children help develop vaccine;

> Shareholders of synthetic vaccine maker Inovio ($INO) have approved a one-for-four reverse stock split. More

> A hepatitis B vaccine administered in infancy can protect a child through late adolescence, a study has shown. Report

> Japan has given Nigeria $85 million for polio eradication. More

> A startup trying to develop a free vaccine to end HIV and AIDS is using crowdsourcing to fund the project. Report

And Finally... A group of children in Tanzania who are naturally immune to malaria are helping scientists develop a new vaccine. More

On-Demand Webinar

Leveraging A Medical Record-Enriched Patient Dataset for COVID-19 Research

You are invited to join a webinar that will explore the ways researchers can leverage this enriched dataset for important COVID-19 research. Sign up today for this informative webinar to learn how you can leverage one of the only medical record reviews solely using real-world data from hospitalized COVID-19 patients.

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.